These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 38622558)
1. Based on molecular docking and real-time PCR technology, the two-component system Bae SR was investigated on the mechanism of drug resistance in CRAB. Pan B; Wang Y; Su J; Liu Y; Yang J; Zhou Y; Sun L BMC Microbiol; 2024 Apr; 24(1):126. PubMed ID: 38622558 [TBL] [Abstract][Full Text] [Related]
2. Carbapenem resistance gene crisis in A. baumannii: a computational analysis. Zahra N; Zeshan B; Ishaq M BMC Microbiol; 2022 Dec; 22(1):290. PubMed ID: 36463105 [TBL] [Abstract][Full Text] [Related]
3. Molecular docking and dynamic approach to screen the drug candidate against the Imipenem-resistant CarO porin in Acinetobacter baumannii. Gopikrishnan M; George Priya Doss C Microb Pathog; 2023 Apr; 177():106049. PubMed ID: 36858184 [TBL] [Abstract][Full Text] [Related]
4. Susceptibility profile of Sharma S; Banerjee T; Yadav G; Kumar A Front Cell Infect Microbiol; 2022; 12():1068840. PubMed ID: 36683677 [TBL] [Abstract][Full Text] [Related]
5. [Mechanism of drug resistance of carbapenems-resistant Acinetobacter baumannii and the application of a combination of drugs in vitro]. Zhao C; Xie W; Zhang W; Ye Z; Wu H Zhonghua Shao Shang Za Zhi; 2014 Apr; 30(2):166-70. PubMed ID: 24989663 [TBL] [Abstract][Full Text] [Related]
6. [In vitro synergistic activity of sulbactam in combination with imipenem, meropenem and cefoperazone against carbapenem-resistant Acinetobacter baumannii isolates]. Turk Dagi H; Kus H; Arslan U; Tuncer I Mikrobiyol Bul; 2014 Apr; 48(2):311-5. PubMed ID: 24819268 [TBL] [Abstract][Full Text] [Related]
7. Individual or Combined Effects of Meropenem, Imipenem, Sulbactam, Colistin, and Tigecycline on Biofilm-Embedded Acinetobacter baumannii and Biofilm Architecture. Wang YC; Kuo SC; Yang YS; Lee YT; Chiu CH; Chuang MF; Lin JC; Chang FY; Chen TL Antimicrob Agents Chemother; 2016 Aug; 60(8):4670-6. PubMed ID: 27216052 [TBL] [Abstract][Full Text] [Related]
8. Emergence of eravacycline heteroresistance in carbapenem-resistant Li YT; Chen XD; Guo YY; Lin SW; Wang MZ; Xu JB; Wang XH; He GH; Tan XX; Zhuo C; Lin ZW Front Cell Infect Microbiol; 2024; 14():1356353. PubMed ID: 38601741 [TBL] [Abstract][Full Text] [Related]
14. In vitro interactions of ambroxol hydrochloride or amlodipine in combination with antibacterial agents against carbapenem-resistant Acinetobacter baumannii. Wang Y; Li X; Wang D; Sun S; Lu C Lett Appl Microbiol; 2020 Mar; 70(3):189-195. PubMed ID: 31808159 [TBL] [Abstract][Full Text] [Related]
15. Differences between meropenem and imipenem disk to detect carbapenemase in gram-negative bacilli using simplified carbapenem inactivation method. Wan D; Jing X; Zhou H; Min X; Zhang X; Wu T; Liu R; Zeng J J Infect Chemother; 2020 Jun; 26(6):636-639. PubMed ID: 32173284 [TBL] [Abstract][Full Text] [Related]
16. Characteristics of carbapenem-resistant Acinetobacter spp. other than Acinetobacter baumannii in South Korea. Park YK; Jung SI; Park KH; Kim SH; Ko KS Int J Antimicrob Agents; 2012 Jan; 39(1):81-5. PubMed ID: 21996405 [TBL] [Abstract][Full Text] [Related]
17. In vitro activity of colistin against multidrug-resistant Acinetobacter baumannii isolates harboring blaOXA-23-like and blaOXA-24-like genes: A multicenter based study. Khanjani S; Sedigh Ebrahim-Saraie H; Shenagari M; Ashraf A; Mojtahedi A; Atrkar Roushan Z Acta Microbiol Immunol Hung; 2020 Mar; 67(3):182-186. PubMed ID: 32160785 [TBL] [Abstract][Full Text] [Related]
18. Molecular docking, dynamics and free energy analyses of Ramachandran B; Jeyakanthan J; Lopes BS J Med Microbiol; 2020 Aug; 69(8):1062-1078. PubMed ID: 32773005 [No Abstract] [Full Text] [Related]
19. Molecular characterization and antibiotic resistance of Acinetobacter baumannii in cerebrospinal fluid and blood. Shi X; Wang H; Wang X; Jing H; Duan R; Qin S; Lv D; Fan Y; Huang Z; Stirling K; Zhang L; Wang J PLoS One; 2021; 16(2):e0247418. PubMed ID: 33617547 [TBL] [Abstract][Full Text] [Related]
20. In vitro activity of ceftazidime/avibactam, imipenem/relebactam and meropenem/vaborbactam alone or in combination with polymyxin B against carbapenem resistant Acinetobacter baumannii. Liang R; Wang D; Hu M; Gu Y; Wang M; Hu D; Zhu M; Wang M J Antibiot (Tokyo); 2023 Sep; 76(9):540-547. PubMed ID: 37217796 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]